Tsveta Milanova serves as Executive at AGIOS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Tsveta Milanova has executed 12 insider transactions totaling $302.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 5, 2026 involved exercising options for 8,475 shares valued at $0.
Tsveta Milanova currently holds 34,793 shares of AGIOS PHARMACEUTICALS, INC. (AGIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tsveta Milanova has been a net seller of AGIO stock. They have purchased $0 and sold $302.7K worth of shares.
Tsveta Milanova's most recent insider trade was on Jan 5, 2026, when they sold 8,475 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $27.02 |
| Discretionary |
| Jan 5, 2026 | AGIO | $0 | Option Exercise | 8,475 | $N/A | Discretionary |
| Dec 30, 2025 | AGIO | $0 | Option Exercise | 6,000 | $N/A | Discretionary |
| Dec 30, 2025 | AGIO | $79.4K | Sale | 2,932 | $27.09 | Discretionary |
| Dec 30, 2025 | AGIO | $0 | Option Exercise | 6,000 | $N/A | Discretionary |
| Jan 24, 2024 | AGIO | $35.0K | Sale | 1,618 | $21.64 | Planned |
| Jan 20, 2024 | AGIO | $0 | Option Exercise | 5,448 | $N/A | Planned |
| Jan 5, 2024 | AGIO | $64.8K | Sale | 2,902 | $22.32 | Planned |
| Jan 3, 2024 | AGIO | $0 | Option Exercise | 8,475 | $N/A | Planned |
| Jun 30, 2023 | AGIO | $45.9K | Sale | 1,618 | $28.36 | Planned |
| Jun 28, 2023 | AGIO | $0 | Option Exercise | 5,449 | $N/A | Planned |